Yuka Suzuki

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 14

Top Topics

Diffuse Large B Cell Lymphoma

Hodgkin Lymphoma

Top Venues

Pathology international

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chizuru Futatsuya, Hiroshi Minato, Yurie Okayama, Kazuyoshi Katayanagi, Hiroshi Kurumaya, Yasuko Matsumoto, Makoto Fukuoka, Yuka Suzuki, Shigeo Nakamura
Interdigitating dendritic cell sarcoma of the spine: Hitherto undescribed lesion. Pathology international 71 (9) (2021)
Daisuke Yamashita, Kazuyuki Shimada, Kei Kohno, Yasunori Kogure, Keisuke Kataoka, Taishi Takahara, Yuka Suzuki, Akira Satou, Ayako Sakakibara, Shigeo Nakamura, Naoko Asano, Seiichi Kato
PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases. Pathology international 70 (8) (2020)
Ayako Sakakibara, Kei Kohno, Eri Ishikawa, Yuka Suzuki, Satoko Shimada, Ahmed E Eladl, Ahmed A Elsayed, Teerada Daroontum, Akira Satou, Taishi Takahara, Akiko Ohashi, Emiko Takahashi, Seiichi Kato, Shigeo Nakamura, Naoko Asano
Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142. Pathology international 70 (8) (2020)
Kei Kohno, Ayako Sakakibara, Akari Iwakoshi, Masaki Hasegawa, Shiro Adachi, Eri Ishikawa, Yuka Suzuki, Satoko Shimada, Masato Nakaguro, Yoshie Shimoyama, Taishi Takahara, Emiko Takahashi, Akiko Ohashi, Akira Satou, Seiichi Kato, Naoko Asano, Shigeo Nakamura
Syncytial variant of classic Hodgkin lymphoma: Four cases diagnosed with the aid of CD274/programmed cell death ligand 1 immunohistochemistry. Pathology international 70 (2) (2020)
Kanae Okada, Taishi Takahara, Yuka Suzuki, Kei Kohno, Ayako Sakakibara, Akira Satou, Emiko Takahashi, Shigeo Nakamura
Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression. Pathology international 71 (1) (2020)
Ayako Sakakibara, Kei Kohno, Akari Iwakoshi, Suzuko Moritani, Aya Fujishiro, Katsuyuki Kito, Yuka Suzuki, Satoko Shimada, Masato Nakaguro, Yoshie Shimoyama, Taishi Takahara, Emiko Takahashi, Akiko Ohashi, Akira Satou, Seiichi Kato, Naoko Asano, Shigeo Nakamura
Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases. Pathology international 70 (2) (2020)
Kei Kohno, Yuka Suzuki, Tomoko Harada, Akihiro Sakai, Yuki Takeuchi, Yuichiro Inagaki, Nirmeen A Megahed, Taishi Takahara, Akira Satou, Ayako Sakakibara, Shigeo Nakamura
Nodal diffuse large B-cell lymphoma with neoplastic PD-L1 positivity, but without EBV association: Three cases highlighting an aspect of gray zone lymphoma. Pathology international 70 (9) (2020)
Nirmeen A Megahed, Kei Kohno, Ayako Sakakibara, Ahmed E Eladl, Ahmed A Elsayed, Chun-Chieh Wu, Yuka Suzuki, Taishi Takahara, Seiichi Kato, Shigeo Nakamura, Akira Satou, Naoko Asano
Anaplastic variant of diffuse large B-cell lymphoma: Reappraisal as a nodal disease with sinusoidal involvement. Pathology international 69 (12) (2020)
Yuka Suzuki, Kei Kohno, Matsue Kosei, Ayako Sakakibara, Eri Ishikawa, Satoko Shimada, Kazuyuki Shimada, Seiyo Mabuchi, Taishi Takahara, Seiichi Kato, Shigeo Nakamura, Akira Satou
PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy. Cancer medicine 9 (13) (2020)
Ahmed E Eladl, Kazuyuki Shimada, Yuka Suzuki, Taishi Takahara, Seiichi Kato, Kei Kohno, Ahmed Ali Elsayed, Chun-Chieh Wu, Takashi Tokunaga, Tomohiro Kinoshita, Mamiko Sakata-Yanagimoto, Shigeo Nakamura, Akira Satou
EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Cancer medicine 9 (2) (2019)
Ayako Sakakibara, Kei Kohno, Naoto Kuroda, Kenji Yorita, Nirmeen A Megahed, Ahmed E Eladl, Teerada Daroontum, Eri Ishikawa, Yuka Suzuki, Satoko Shimada, Masato Nakaguro, Yoshie Shimoyama, Akira Satou, Seiichi Kato, Yasushi Yatabe, Naoko Asano, Shigeo Nakamura
Anaplastic variant of diffuse large B-cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics. Pathology international 68 (4) (2018)
Ayako Sakakibara, Kei Kohno, Ahmed E Eladl, Teerada Klaisuwan, Eri Ishikawa, Yuka Suzuki, Satoko Shimada, Masato Nakaguro, Yoshie Shimoyama, Taishi Takahara, Seiichi Kato, Naoko Asano, Shigeo Nakamura, Akira Satou
Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells. Histopathology 72 (7) (2018)
Eri Ishikawa, Seiichi Kato, Kazuyuki Shimada, Tsutomu Tanaka, Yuka Suzuki, Akira Satou, Kei Kohno, Ayako Sakakibara, Takeshi Yamamura, Masanao Nakamura, Ryoji Miyahara, Hidemi Goto, Shigeo Nakamura, Yoshiki Hirooka
Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells. Cancer medicine 7 (12) (2018)
Yuka Suzuki, Seiichi Kato, Kei Kohno, Akira Satou, Ahmed E Eladl, Naoko Asano, Michihiro Kono, Yuichi Kato, Masafumi Taniwaki, Masashi Akiyama, Shigeo Nakamura
Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms. Histopathology 71 (6) (2017)